Ascentage Pharma Group In...

NASDAQ: AAPG · Real-Time Price · USD
46.86
0.46 (1.00%)
At close: Aug 20, 2025, 9:40 AM

Ascentage Pharma International Cash Flow Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-395.25M -932.86M -887.17M -832.25M
Depreciation & Amortization
93.17M 93.19M 9.13M 4.39M
Stock-Based Compensation
20.92M 31.5M 22.11M 46.97M
Other Working Capital
19.13M 112.22M 85.62M 247.55M
Other Non-Cash Items
58.84M 91.23M 1.97M -37.38M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
110.97M -9.15M 12.49M 189.65M
Operating Cash Flow
-111.36M -726.08M -653.91M -604.68M
Capital Expenditures
-24.29M -56.84M -236.96M -436.63M
Cash Acquisitions
-1.32M -20M -20M -3.05M
Purchase of Investments
-45.61M n/a -130M -1.78B
Sales Maturities Of Investments
n/a n/a n/a 1.79B
Other Investing Acitivies
-312.23M 88.03M -31.32M -879K
Investing Cash Flow
-362.04M 21.92M -384.61M -466.52M
Debt Repayment
-145.34M -13.36M 695.87M 548.59M
Common Stock Repurchased
n/a -835.99K -26.78M -4.01M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-73.83M -82.05M -49.83M -41.97M
Financial Cash Flow
314.77M 368.75M 619.27M 1.78B
Net Cash Flow
-144.95M -307.59M -361.25M 686.91M
Free Cash Flow
-135.65M -782.92M -890.88M -1.04B